Participation in NCBiR project

2017-11-15 01:00

BioResearch took part in and won a tender for new, innovative clinical study with esketamine, sponsored by Celon Pharma S.A. Due to our experience, engagement and professional approach, our offer was the most attractive and well-prepared.

The study will begin in December, the clinical part will be conducted in our Site in Kajetany.

Go back

News

2021-03-22 14:37

COVID-19 Vaccine AstraZeneca® – conclusion of EMA review of usage safety in reference to the thromboembolic events following vaccination

The European Medicines Agency’s (EMA) Pharmacovigilance...

2020-12-22 15:14

Merry Christmas and Happy New Year

Let the magical night of Christmas Eve bring peace and joy. Let every moment of Christmas live with its own beauty, and bestows the New Year with prosperity and happiness.

2020-11-05 14:10

COVID -19 Antigen Tests:

On 31^st of October 2020, the Chief Sanitary Inspectorate confirmed that the antigen cassette tests are the same basis for determining the SARS-CoV-2 ...

BRG team participated in BIO-Europe®

On 26th -27th of October BRG team participated in BIO-Europe® the largest partnering conference in Europe dedicated to the global biotechnology industry.

2020-10-12 12:21

BRG Team participated in the official opening of the Celon Pharma Research and Development Center

On September 28, 2020 BRG Team participated in the official opening of the Celon Pharma Research and Development Center

Page 4 of 10